11.78

8.96% -1.16

After Hours: 11.78

Forte Biosciences Inc (FBRX)

Overview News Price History Option Chain Financials Discussions Forecast

Forte Biosciences Inc stock is traded at $11.78, with a volume of 61,412. It is down -8.96% in the last 24 hours and down -23.95% over the past month. Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Previous Close:

$12.94

Open:

$12.94

24h Volume:

61,412

Relative Volume:

0.69

Market Cap:

$146.46M

Revenue:

Net Income/Loss:

$-31.48M

P/E Ratio:

-11.33

EPS:

-1.04

Net Cash Flow:

$-28.71M

1W Performance:

-9.38%

1M Performance:

-23.95%

6M Performance:

+69.25%

1Y Performance:

+181.82%

1-Day Range:

$11.58

$13.46

1-Week Range:

$11.58

$15.10

52-Week Range:

$4.12

$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name

Forte Biosciences Inc

Sector

Healthcare (1136)

Industry

Biotechnology (633)

Phone

(310) 618-6994

Address

3060 PEGASUS PARK DRIVE, DALLAS, CA

Employee

Twitter

Next Earnings Date

2024-11-11

Latest SEC Filings

FBRX's Discussions on Twitter

Compare FBRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FBRX Forte Biosciences Inc	11.78	160.88M	0	-31.48M	-28.71M	-1.04
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-25	Initiated	Guggenheim	Buy
Jan-21-25	Initiated	TD Cowen	Buy
Apr-08-24	Upgrade	Ladenburg Thalmann	Neutral → Buy
Sep-20-21	Upgrade	Chardan Capital Markets	Sell → Buy
Sep-03-21	Downgrade	B. Riley Securities	Buy → Neutral
Sep-03-21	Downgrade	Chardan Capital Markets	Buy → Sell
Sep-03-21	Downgrade	Ladenburg Thalmann	Buy → Neutral
Sep-03-21	Downgrade	Truist	Buy → Hold
May-14-21	Initiated	B. Riley Securities	Buy
Mar-26-21	Initiated	Citigroup	Buy
Aug-28-20	Upgrade	Chardan Capital Markets	Neutral → Buy
Aug-25-20	Initiated	Truist	Buy

View All

Forte Biosciences Inc Stock (FBRX) Latest News

04:37 AM

Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Significant Growth in Short Interest - MarketBeat

04:37 AM

04:01 AM

Forte Biosciences, Inc. to Present at Upcoming Healthcare Conferences - Bluefield Daily Telegraph

04:01 AM

Forte Bio (NASDAQ: FBRX) to present at Guggenheim, TD Cowen, Evercore in Nov-Dec - Stock Titan

04:01 AM

10:03 AM

How Forte Biosciences Inc. stock performs after earningsJuly 2025 Selloffs & Weekly Watchlist for Consistent Profits - newser.com

10:03 AM

09:31 AM

Why Forte Biosciences Inc. stock appeals to analystsSell Signal & Precise Swing Trade Entry Alerts - newser.com

09:31 AM

09:04 AM

Signal strength of Forte Biosciences Inc. stock in tech scannersJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com

09:04 AM

08:25 AM

Is Forte Biosciences Inc. stock affected by interest rate hikes2025 Technical Overview & High Accuracy Trade Alerts - newser.com

08:25 AM

06:28 AM

Why Forte Biosciences Inc. stock is in analyst buy zone2025 Momentum Check & Weekly Return Optimization Alerts - newser.com

06:28 AM

04:02 AM